DHealthPsy, Health Psychology
Staffordshire University, Stoke-on-Kent, United Kingdom
MSc, Health Psychology
University of Bath, Bath, United Kingdom
BSc, Psychology
Manchester Metropolitan University, Manchester, United Kingdom
Sheryl Warttig has experience in a broad range of therapy areas, including diabetes, oncology, digestive tract diseases, infectious diseases, surgical care, pain management, and medtech (including diagnostics and digital technologies). In her current role at RTI-HS, Ms. Warttig performs primary and secondary research to support the development of evidence-based dossiers, systematic literature reviews, landscaping activities, health technology assessment (HTA) submissions, outcomes research strategies, and payer research for pharmaceuticals and medtech (including diagnostics and digital technologies). She has also led the development of several Cochrane systematic reviews on a range of topics. Prior to joining RTI-HS, Ms. Warttig worked for over 10 years at the National Institute of Health and Care Excellence (NICE) where she led the development of NICE guidelines and NICE HTA’s in a range of topic areas, and supported companies to go through NICE’s HTA processes.